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Store-operated Ca2 entry is exaggerated in fresh
preglomerular vascular smooth muscle cells of SHR
SUSAN K. FELLNER and WILLIAM J. ARENDSHORST
Department of Cell and Molecular Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Store-operated Ca2 entry is exaggerated in fresh preglomeru- Genetic hypertension is likely the result of a constella-
lar vascular smooth muscle cells of SHR. tion of renal epithelial cell transport and renal vascular
Background. Regulation of preglomerular vasomotor tone abnormalities, no one of which in isolation causes pro-vessels ultimately control glomerular filtration rate, sodium
nounced and sustained blood pressure elevation. How-reabsorption and systemic blood pressure. To gain insight into
ever, acting in concert and probably influenced by envi-the complex renal hemodynamic factors that may result in
hypertension, we studied calcium signaling pathways. ronmental factors, these abnormal mosaics may create
Methods. Fresh, single, preglomerular vascular smooth mus- a variety of patterns of so-called essential hypertension in
cle cells (VSMC) were isolated from 5- to 6-week-old SHR and humans. The spontaneously hypertensive rat (SHR) andWKY utilizing a magnetized microsphere/sieving technique.
its normotensive control, the Wistar-Kyoto rat (WKY),Cytosolic Ca2 ([Ca2]i) was measured with fura-2 ratiometric
have been the focus of extensive investigations into thefluorescence. To examine store-operated calcium entry (SOC),
VSMC were activated in calcium-free buffer containing nifedi- pathogenesis of genetic hypertension characterized by
pine. To deplete the sarcoplasmic reticulum (SR) of Ca2, excessive constriction of peripheral and renal resistance
vasopressin-1 receptor agonist [V1R; inositol trisphosphate vessels [1].
(IP3)-mediated mobilization], ryanodine (non-IP3 induced mo- Previous studies from our laboratory have identifiedbilization), and cyclopiazonic acid (CPA; Ca2-ATPase inhibi-
major abnormalities of calcium signaling in preglomeru-tion) were utilized. Addition of external calcium followed by
quenching of the fura/Ca2 signal with Mn2 permitted assess- lar vascular smooth muscle cells (VSMC) of young SHR
ment of divalent cation entry via SOC. compared to WKY. Arginine vasopressin (AVP) causes
Results. V1R caused greater mobilization in SHR than WKY exaggerated stimulation of V1 receptors and vasoconstric-(P 0.01) as well as greater calcium entry (P 0.001). Ryano-
tion in the renal microcirculation of SHR [2, 3]. The straindine and CPA both caused SR calcium depletion that was
difference in renal vascular reactivity in vivo is observednot statistically different between strains, but absolute calcium
entry through SOC was more than double in SHR following in the presence or absence of blockade of arachidonic acid-
either maneuver (P 0.001). 2-Amino-ethoxybiphenyl borane cyclooxygenase metabolism with indomethacin. Calcium
(2-APB), an inhibitor not only of IP3 receptors, but also of SOC, entry via L-type voltage-gated channels and inositol tri-
blocked calcium entry in the ryanodine and CPA experiments
phosphate (IP3)-mediated mobilization from the sarco-independent of IP3. As well, Gd3, a selective inhibitor of SOC,
plasmic reticulum (SR) are of greater absolute magni-inhibited the Ca2 response. We also studied L-channel calcium
entry stimulated by V1R. The total calcium response was tude in SHR [3]. When analyzed as percent of the total
greater in SHR as was the absolute inhibition by nifedipine. renal blood flow response, mobilization and calcium en-
As a percent of the total response, participation of L-type try through L-type channels were similar in both strains
channels sensitive to nifedipine was about 45% in both strains of rat. Such functional responses are consistent with theof rat.
finding that renal resistance vessels of young SHR haveConclusion: Utilizing three separate mechanisms to deplete
a higher density of V1 receptors associated with increasedthe SR of Ca2 in order to activate SOC, we show for the
first time, that SOC is exaggerated in preglomerular VSMC of gene expression [4]. Single cell data suggest renal VSMC
young SHR. exhibit a greater response to V1R stimulation, a response
mediated at least in part by L-type calcium channels [2].
In contrast, the mechanism responsible for the exag-
Key words: ryanodine, cyclopiazonic acid, vasopressin, l-type channels,
gerated vasoconstrictor response to angiotensin II (Angcapacitative calcium entry, 2-aminoethoxy biphenyl borane (2-APB),
calcium signaling, gadolinium. II) in SHR does not involve a change in Ang II subtype
1 (AT) receptor density [5]. Rather, SHR demonstrateReceived for publication September 21, 2001
impaired ability of vasodilator prostaglandins (PG) toand in revised form February 4, 2002
Accepted for publication February 5, 2002 buffer the vasoconstrictor effects of Ang II [6]. The cause
of the impaired buffering mechanism is thought to arise 2002 by the International Society of Nephrology
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from inadequate activation of adenyl cyclase that is due and 0.1% bovine serum albumin (BSA) for 45 to 60
minutes at room temperature in the dark. After washingto inefficient coupling of the dopamine-1, prostaglandin
E2 (PGE2) and PGI2 receptors to stimulatory G proteins with buffer (pH 7.4), cells were kept on ice either in
buffer with 1 mmol/L MgCl2 (nominally calcium-free)[7, 8]. Prostaglandin E2 and prostacyclin function nor-
mally to antagonize Ang II-induced calcium signaling in or buffer with 1.0 mmol/L MgCl2 and 1.1 mmol/L CaCl2.
preglomerular VSMC by attenuating IP3-mediated cal-
Measurement of cytosolic free calcium concentrationcium release from the SR [9].
A number of investigators have examined voltage- Cytosolic free calcium concentration ([Ca2]i) was
measured as previously described [15, 16]. A very dilutegated L-type channel activity in a variety of non-renal
vessels of both young and old adult SHR compared to suspension of VSMC in an open static chamber was
examined in a small window of the optical field of aWKY [10–13]. In general, L-type channel activity ap-
pears to be increased in SHR. The only laboratory that X40 oil-immersion fluorescence objective of an inverted
microscope (Olympus IX70). VSMC, identified morpho-has studied renal resistance arterioles reports that West-
ern blot analysis of L-type Ca2 channel (a1c) protein of logically by their spindle or crescent shape, have been
shown previously to stain with smooth muscle specificdissociated VSMC appeared to be similar in 30-week-
old SHR and WKY [14]. alpha-actin and heavy chain myosin SM-1 and SM-2 [17].
Care was taken to focus and record from only one orWe have recently shown that calcium entry in VSMC
of preglomerular resistance vessels of normotensive rats two VSMC. The VSMC were excited alternately with
light of 340 and 380 nm wavelengths from a dual-excita-is mediated by both voltage-gated L-type channels and
store-operated calcium entry channels (SOC) [15]. As tion wavelength Delta-Scan equipped with dual mono-
chronometers and a chopper [Photon Technology Inter-well, we found that these VSMC have ryanodine sensi-
tive receptors (RyR) and that depletion of the SR by national (PTI), Lawrenceville, NJ, USA]. The calibration
of [Ca2]i was based on the signal ratio at 340/380 nmstimulating the RyR can activate SOC [15].
The aim of the present investigation was to examine and known concentrations of calcium [15, 16, 18]. For
Mn2 quenching experiments, the fluorescence signal wascalcium entry through SOC channels induced by three
different mechanisms for depleting SR calcium stores, quantified at 360 nm to document that Mn2 indeed
quenched the fura/Ca2 signal [19].namely IP3 receptor activation with AVP, inhibition of
SR calcium ATP-ase with cyclopiazonic acid (CPA) and Ratiometric tracings of response to V1R generally
demonstrated a square wave configuration characterizedstimulation of the RyR with ryanodine in renal arteriolar
VSMC freshly isolated from young SHR and WKY. As by an immediate step increase, although in some cases
an initial peak was observed, the latter tending to occurwell, we sought a strain difference in voltage-gated L-chan-
nel activity in VSMC of preglomerular arterioles. when the ambient temperature was 26C. Such re-
sponses are not unique to our laboratory. Variations in
temperature and concentrations of agonists employed
METHODS
may account for some of the differences observed. Previ-
Preparation of preglomerular resistance vessels ous work on the effects of temperature on calcium mobi-
lization, reuptake and entry have shown that IP3-inducedThe magnetized polystyrene microsphere-sieving tech-
nique previously described by our laboratory [15, 16] release of intracellular Ca2 is relatively temperature
insensitive but that the overall rate of the processes forwas employed to isolate preglomerular vessels (50 m
in diameter) from 5- to 6-week-old WKY and SHR main- removal of [Ca2]i are significantly reduced at 27C, lead-
ing to a square, rather than peak/plateau morphology oftained in our Chapel Hill colony. The vessels were
treated with collagenase (Sigma, type 1-A) for 15 to 30 the response [20]. Nonetheless, square wave responses
at 35 to 38C to norepinephrine [21, 22] and angiotensinminutes at 34C. Following collagenase treatment and
washing, the suspension was triturated to disrupt the [23, 24] have been reported for VSMC or intact vessels
by a number of laboratories. Both ryanodine and CPAvascular wall of the small vessels. Light microscopic ex-
amination of an aliquot of the suspension confirmed the however, typically produced a waveform that did not
have a peak/plateau configuration. When the recordingpresence of single VSMCs, an occasional glomerulus and
intact larger arteries. The concentration of collagenase period is short (1 min), the response showed a square
or ascending shape.(0.005 to 0.01%) and time of incubation were adjusted
for each batch collagenase on a weekly basis to ensure
Protocolthat vessels larger than interlobular arteries were not
digested. A third magnet step removed undigested ves- Unless stated otherwise, VSMCs were prepared in
nominally calcium-free buffers ([Ca2] 200 nmol/L),sels and any remaining glomeruli leaving free vascular
smooth muscle cells in the suspension. Vascular smooth whereas the buffer containing egtazic acid (EGTA),
which was added immediately prior to examination of amuscle cells were loaded with 2 to 3 mol/L fura-2-AM
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VSMC, contained 20 nmol/L Ca2. Because reagents
were added sequentially, the concentrations of the added
solutions were adjusted to achieve the desired final con-
centration in the new volume. Experiments were per-
formed at a temperature of 25 to 27C to help minimize
fura-2 leakage from cells. To assure that leakage of fura-2
from the VSMCs into the supernatant did not occur, two
controls were performed. External calcium (1 mmol/L)
was added to VSMCs to show that baseline [Ca2]i did
not change; then, an agonist was added to demonstrate
that the cell was indeed viable. As well, experiments in
which Mn2 was added to the cell suspension in the
absence of agonist showed no significant fall in baseline
[Ca2]I, which would be predicted if appreciable free
fura-2 were present in the suspension (Fig. 3) [16].
Fig. 1. Cytosolic calcium response of preglomerular vascular smoothTo demonstrate store-operated calcium entry, empty- muscle cells (VSMC) to vasopressin-1 receptor agonist (V1R) at two
ing of the SR was achieved by stimulation with V1R to concentrations (107 and 106 mol/L). There was no difference within
strain to either concentration. SHR () had an exaggerated responseactivate the IP3 pathway, with ryanodine to open the
compared to WKY (); *P  0.01.ryanodine-sensitive receptor (RyR) or with CPA to
block reuptake of sarcolemmal Ca2 by inhibiting the
Ca2 ATPase. To assure that calcium entry via voltage- an exaggerated calcium response to vasopressin and V1
gated L-type channels did not occur, VSMC were pre- receptor stimulation compared to WKY, were confirmed
treated with nifedipine. [2]. Responses to V1R agonist at concentrations of either
107 or 106 mol/L did not differ statistically from eachReagents
other within strains (P  0.10 for both), demonstrating
Collagenase, EGTA, MnCl2, and nifedipine came from attainment of a maximal effect with the lower dose
Sigma Chemical Co. (St. Louis, MO, USA), cyclopi- tested. Baseline values were similar in the two strains:
azonic acid and ryanodine from Cal Biochem (La Jolla, 78  7 and 84  6 nmol/L for WKY (N  10) and 87 
CA, USA), vasopressin-1 receptor agonist ([Phe2, Ile3, 5 and 101  6 nmol/L for SHR (N  11). However, V1ROrn8]-Vasopressin; V1R) from Peninsula Laboratories stimulation, at either concentration, caused a greater
(Belmont, CA, USA), and fura-2-AM from Molecular increase in [Ca2]i in SHR: 71 11 versus 55 10 nmol/LProbes (Eugene, OR, USA) or Teflab (Austin, TX, at 107 V1R and 117  13 versus 67  10 nmol/L at 106USA). 2-Amino-ethoxydiphenyl borane (2-APB) was a mol/L V1R (both P  0.01; Fig. 1). Having establishedgenerous gift of Dr. Gary Bird (National Institute of
a strain difference in global response to V1R stimulation,Environmental and Health Science, Research Triangle
individual pathways of calcium mobilization and entryPark, NC, USA).
in preglomerular VSMC were examined in more detail.
L-type voltage gated Ca2 entry. Our previous studyStatistics
showed that L-type channel activity accounts for approx-The data are presented as means  SEM. Each data
imately 50% of agonist-induced calcium entry in freshset is derived from VSMC originating from at least three
VSMC derived from preglomerular resistance vesselsseparate experimental days, two to three rats (4 to 6
when stimulated with Ang II or AVP [15]. Thus, wekidneys) per day or a minimum of six to nine rats per
studied the effect of the L-channel blocker nifedipinestudy set. Individual cells were studied only once and
(3 	 107 mol/L) on AVP stimulated calcium entry.then discarded. Paired data sets were tested with the
Figure 2 shows typical responses of SHR preglomerularStudent paired t test. Multiple comparisons were ana-
VSMC to V1R (107 mol/L) stimulation when nifedipinelyzed using one-way analysis of variance (ANOVA) for
is given either before or after the peptide agonist. Quali-repeated measures followed by Student-Neuman-Kuels
tatively, responses in WKY were not different. Baselinepost hoc test. P  0.05 was considered statistically sig-
[Ca2]i was similar in groups of WKY and SHR, averag-nificant.
ing 90  8 and 93  10 nmol/L. Stimulation with V1R
increased [Ca2]i to 165  10 and 204  23 nmol/L,RESULTS respectively. The increase was greater in SHR (P 
Global response of VSMC to V1R 0.05). Subsequent addition of nifedipine (107 mol/L)
decreased [Ca2]i to 134  10 in WKY and 152  18The basic findings of previous studies from our labora-
tory, showing that preglomerular VSMC of SHR exhibit nmol/L in SHR. Although the absolute decline was
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Fig. 2. Representative tracings in single SHR VSMC showing effect
of blockade of voltage-gated L-type channels by nifedipine. Nifedipine
was given after (A) or before (B) stimulation of cytosolic calcium with
vasopressin-1 receptor agonist (V1R). Nifedipine (3	 107 mol/L) given
after V1R blocked the response by about 50%. Prior treatment with
nifedipine blunts the response to V1R.
greater in VSMC of SHR, the percent inhibition by Fig. 3. Temporal responses of single preglomerular VSMC in calcium-
free buffer containing nifedipine and EGTA in WKY () and SHRL-type channel blockade was similar (43 vs. 47%). Other
(). (A) Addition of V1R stimulates mobilization of Ca2 from the SRstudies established that a higher concentration of nifedi- to a greater extent in SHR (*P  0.01 for V1R compared to baseline).
pine (3 	 106 mol/L) produced the same degree of Provision of extracellular Ca2 (1 mmol/L) during ongoing L-type
channel blockade with nifedipine, permits greater Ca2 entry via SOCinhibition of V1R stimulation (data not shown).
in SHR (**P  0.001). Addition of Mn2 (100 mol/L) quenches theStore-operated calcium entry. To examine store-oper- Ca/fura signal. (B) Sequential responses of VSMC (SHR) to V1R, calcium
ated Ca2 entry, fresh renal VSMC were pretreated with and Gd3. Gadolinium selectively inhibits calcium entry via SOC.
Ca-free medium containing EGTA (0.5 mmol/L) and
nifedipine (3 	 107 mol/L). V1 receptor agonist was
added to stimulate Ca2 mobilization from the SR and of Mn2 to unstimulated cells or supernatant change
resting [Ca2]i values [16]. Figure 3A shows that baselinethen exogenous calcium (1 mmol/L) was added to the
medium to permit calcium entry through non voltage- [Ca2]i of VSMC in calcium-free buffer containing
EGTA and nifedipine to block voltage-gated L-typegated channels. Lastly, Mn2 (100 mol/L) was added
to document divalent cation entry into the cell by its channels was identical in WKY and SHR [71  5 (N 
25) and 72  4 nmol/L (N 38)], respectively. Additionability to quench the fura/Ca2 signal. An important con-
trol for such studies is the demonstration that the addi- of V1 receptor agonist (107 mol/L) caused an immediate
release of Ca2 from the SR, presumably via stimulationtion of calcium to unstimulated VSMC in calcium-free
medium does not alter [Ca2]i [16]. Neither did addition of the IP3 receptor. [Ca2]i rose to 92  5 nmol/L in
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WKY (N  25) and to 107  6 nmol/L in SHR (N 
38), a greater increase in SHR (P  0.005). Subsequent
addition of external calcium (1 mmol/L) permitted
Ca2 entry via non-L-type channels, causing [Ca2]i in-
creases of 66  10 nmol/L in WKY and of 101  11
nmol/L in SHR (P  0.001 for both). Thus, calcium
entry distinct from nifedipine sensitive L-type calcium
channels was greater in SHR (P  0.001). In each case,
the Ca2/fura signal was quenched by subsequent addi-
tion of extracellular Mn2. Gadolinium (108 to 106
mol/L), a selective and irreversible blocker of the capaci-
tative or store-operated calcium entry pathway [25] was
tested some experiments. Gd3 (107 mol/L) rather than
Mn2 was added at the end of an experiment to show
inhibition of calcium entry via SOC in WKY and SHR.
Gd3 inhibited the [Ca2]i response to V1R by 50 to 75%.
A representative original tracing in SHR is illustrated
in Figure 3B. These studies establish that V1R activation
stimulated greater mobilization of Ca2 from the SR
in preglomerular VSMC of SHR compared to WKY.
Moreover, SOC was significantly exaggerated in SHR.
Because activation of SOC appears to depend upon
generic depletion of SR stores of calcium, we could not
ascertain the extent to which V1R-induced exaggerated
SOC activity in SHR was dependent on IP3 generation,
IP3 receptor activity, or other steps in mobilization. To
gain further insight into mechanisms capable of activat-
ing SOC, we tested whether SOC could be activated by
SR depletion of calcium by non-IP3 related mechanisms.
In this regard, ryanodine receptors (RyR) are present
in preglomerular resistance vessels and their stimulation
is known to activate SOC [15]. To provide further sup-
port for exaggerated SOC channel activity in renal VSMC
of young SHR, additional experiments were conducted
Fig. 4. Representative tracings of cytosolic calcium response of preglo-utilizing ryanodine stimulation to mobilize calcium stores.
merular VSMC of SHR () and WKY (). (A) Cells of both strainsRyanodine (3 	 106 mol/L), a concentration known to
in calcium-free buffer containing nifedipine (3	 107 mol/L) and EGTA
open RyR channels [16], stimulated [Ca2]i to a similar (0.5 mmol/L) responds similarly to stimulation of the RyR with ryano-
dine (3	 106 mol/L). Addition of Ca2 to the external medium duringextent in the absence of Ca entry (22 vs. 28 nmol/L,
ongoing inhibition of L-type channels allows a twofold greater entryP  0.1). When extracellular Ca2 was provided, entry
of Ca2 via SOC channels in SHR compared to WKY. Mn2 quenches
occurred through channels unaffected by nifedipine. the Ca/fura signal. (B) Response of single WKY VSMC in calcium-
containing buffer to ryanodine. Addition of Gd3 inhibits calcium entrySuch entry through SOC channels was considerably
via SOC.greater in renal VSMC from SHR. Baseline [Ca2]i in
EGTA calcium-free buffer containing nifedipine in
WKY (N  18) was 70  5 and in SHR (N  20), 79 
addition of ryanodine and external Ca2 are shown in2 nmol/L. Ryanodine stimulated calcium release from
Figure 4A. As well, experiments were performed inthe SR (P  0.01 for ryanodine compared to baseline
which Gd3 was added to inhibit SOC. Figure 4B illus-for both), but there was no strain difference in response
trates the response of a preglomerular VSMC from WKY(22 vs. 28 nmol/L, P  0.1). However, subsequent addi-
in calcium containing buffer to ryanodine followed bytion of external calcium revealed exaggerated calcium
addition of Gd3.entry via SOC in SHR. The increase in [Ca2]i after
To further document that ryanodine-induced deple-ryanodine receptor (RyR) stimulation in WKY was 61
tion of calcium stores from the SR stimulates SOC and6 nmol/L and in SHR, 152  7 nmol/L (P  0.001). As
that SOC is exaggerated in SHR, the reagent 2-amino-with the V1R experiments, Mn2 quenching was per-
ethoxydiphenyl borane (2-APB) was utilized. 2-APB hasformed in each experiment. Representative tracings of
the response in a VSMC of SHR and WKY to sequential been used to inhibit the IP3 receptor in several experi-
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in both strains are provided in Figure 5B. In WKY pre-
glomerular VSMC, ryanodine stimulated [Ca2]i from a
baseline of 74  11 to 124  8 nmol/L (N  8). Subse-
quent addition of 2-APB reduced [Ca2]i to a nadir of
71  13 nmol/L in the normotensive group. In SHR,
ryanodine increased [Ca2]i from 70  7 to 163  12
nmol/L. It was reduced to 85 10 nmol/L after addition
of 2-APB (N  12). The absolute increase in [Ca2]i of
VSMC to ryanodine was greater in SHR than WKY (P
0.02). The stimulation was almost completely reversed by
2-APB, suggesting that the late sustained phase of Ca2
entry is mediated largely, if not exclusively, by SOC.
When VSMC were pretreated with 2-APB to block SOC,
the calcium response to ryanodine likely represented
calcium mobilization. In WKY, ryanodine stimulated
[Ca2]i by 25  3 nmol/L (N  8) in the presence of
2-APB compared to 32  3 nmol/L in SHR (N  7).
The 28% greater response in SHR was not statistically
significant (P  0.3). Thus, these data do not provide
convincing evidence for greater ryanodine-induced re-
lease of Ca2 from SR stores in SHR. The degree of
ryanodine stimulation of mobilization in SHR and WKY
is essentially identical to that obtained in calcium-free
(EGTA) buffer [16]. These observations demonstrate
that blockade of SOC by 2-APB mimics the conditions
of calcium-free external medium that preclude calcium
entry.
Inhibition of the SR Ca2-ATPase with either CPA or
thapsigargin (TG) depletes SR Ca2 stores by preventing
Fig. 5. Cytosolic Ca2 response of VSMC to ryanodine and 2-APB. uptake of Ca2 from the cytosol into the SR. We have
(A) Representative tracing of WKY VSMC shows sustained response previously shown that CPA and TG stimulate SOC inover 100 sec to ryanodine prior to the addition of 2-APB. 2-APB
VSMC derived from preglomerular resistance vessels ofreverses the ryanodine-induced calcium response. (B) Mean values for
baseline [Ca2]i and sequential effects of ryanodine (3 	 106 mol/L) WKY [15]. The current study compared the effect of
and 2-amino-ethoxydiphenyl borane (2-APB; 50 to 75 	 106 mol/L) inhibition of SR Ca2-ATPase on Ca2 mobilization andin SHR and WKY. Symbols are: ( ) baseline; () ryanodine; ( )
entry via SOC in SHR versus WKY. Figure 6 is a repre-ryanodine  2-APB. The global response to ryanodine is greater in
SHR (*P  0.05). During continued ryanodine exposure, 2-APB, by sentative original tracing of a single VSMC from SHR,
inhibiting calcium entry via SOC, returns [Ca2]i to baseline values. showing inhibition of SR Ca2-ATPase by CPA, entry
of calcium when calcium is added to the external me-
dium, and quenching of the fura/Ca2 signal with Mn2.
mental models [26–28] and more recent studies show For this series of experiments, baseline [Ca2]i in cal-that 2-APB can block SOC independently of IP3 [29–31]. cium-free (EGTA) buffer containing nifedipine was 80
Thus, we examined the effect of 2-APB (50 to 75mol/L) 6 in SHR (N  17) and 69  6 nmol/L in WKY (N 
on SOC activity before or after stimulation of VSMC 19) (P  0.2). Following the addition of CPA, [Ca2]i
with ryanodine (3 mol/L). Because IP3 is not involved rose by 44  9 nmol/L in SHR and by 32  3 nmol/L
in the mobilization of calcium from the SR after stimula- in WKY, suggesting that there was no marked difference
tion of the RyR with ryanodine, the action of 2-APB is in response to CPA between the two strains. In contrast,
limited to its action on calcium entry via SOC channels. when Ca2 was added to the bathing buffer in the pres-
The representative experiment in Figure 5A demon- ence of nifedipine and blockade of L-type channels, Ca2
strates that the [Ca2]i response to ryanodine in a VSMC entry via SOC was exaggerated in SHR. [Ca2]i increased
from an SHR persists for at least 100 seconds prior to by 132  16 nmol/L in SHR compared to a change of
the addition of 2-APB, and that the increase in [Ca2]i 59 15 nmol/L in WKY (P 0.001). Thus, when refilling
of 125 nmol/L most likely represents the sum of calcium of SR calcium pools is prevented by CPA, the ensuing
mobilization (32 nmol/L, vide infra) and calcium entry depletion of SR calcium stores activates SOC, permitting
via SOC. Subsequent addition of 2-APB reverses the entry of external divalent cation via a non-L-type chan-
nel pathway.calcium response. Group averages for the experiments
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tor agonist to test the effects of peptide agonist stimula-
tion of Gq protein, phospholipase C activation and sub-
sequent IP3 formation because work from our laboratory
has shown exaggerated responses to vasopressin in renal
VSMC of young SHR [2]. As well, in vivo experiments
indicated enhanced renal vascular reactivity to vasopres-
sin in 6-week-old SHR versus WKY [3]. Recently, renal
resistance vessels of young SHR have been shown to
have a higher density of V1 receptors associated with
increased gene expression compared to WKY [4]. Thus,
we predicted that VSMC of SHR would have greater
calcium mobilization or entry or both. Our previous ob-
servation, that vasopressin, and specifically, V1R stimula-
tion, causes an exaggerated [Ca2]i response in young
SHR was confirmed [2]. These earlier findings were ex-
tended by showing that in calcium-free buffer containing
EGTA, V1R stimulates Ca2 mobilization from the SR.
Because concentrations of Mg2 greater than 1 mmol/L
can inhibit the binding of IP3 to its receptor [32], the
previous studies suggesting lack of mobilization with
Fig. 6. Temporal response of a SHR VSMC in buffer containing EGTA Ang II and AVP may have resulted from high concentra-
and nifedipine (107 mol/L) to cyclopiazonic acid (CPA; 106 mol/L). tions of extracellular Mg2 [2].
Addition of extracellular Ca2 (1 	 103 mol/L) permits Ca2 entry
Store operated-calcium entry (capacitative calcium en-via SOC followed by quenching of the fura/Ca2 signal with Mn2.
try) is that mechanism whereby emptying of SR Ca2 by
any means stimulates the opening or insertion of a cal-
cium influx channel [33]. Depletion of SR stores of Ca2DISCUSSION
may be achieved by activation of IP3 receptors, activationInsight into the causes of primary hypertension in hu-
of the RyR or inhibition of the SR Ca2-ATPase [15,mans has long been sought in animal models of genetic
16, 33–35]. Initially described in non-excitable cells, SOChypertension. Young SHR during the developmental
is now being identified in both conduit and resistancestage of hypertension have an increased renal vascular
blood vessels [36]. Precisely how depletion of intracellu-resistance, reduced glomerular filtration rate and a
lar calcium stores activates a SOC channel is uncertaingreater retention of salt and water compared to age-
[37]. We have previously demonstrated the functionalmatched WKY [1]. Because preglomerular arterioles are
presence of SOC in preglomerular VSMC in response
important regulators of renal vascular resistance and glo-
to SR Ca2 depletion by stimulation with V1R, Ang II ormerular capillary pressure, these vessels are uniquely ryanodine, or with inhibition of the SR Ca2-ATPase
positioned to produce major effects on systemic blood with CPA or TG [15, 16]. Consistent with our results,
pressure through the complex interplay of arterial vol- other investigators have found only partial inhibition of
ume and of neural, hormonal and paracrine factors. Ang II-stimulated calcium entry by the L-channel blocker
Blood vessels of SHR from other vascular beds may or nifedipine in superficial and juxtamedullary afferent ar-
may not share with renal resistance vessels abnormalities terioles [23]. Calcium entry through SOC has been iden-
that predispose to the development of hypertension. tified in cultured human mesangial cells [38, 39] and fresh
Analyses of the physiologic abnormalities of VSMC ob- Sprague-Dawley rat efferent arterioles [40].
tained from older (more than 12 weeks) SHR may reflect We have stimulated depletion of SR calcium stores in
the consequences of hypertension rather than the pri- preglomerular VSMC by three independent mechanisms
mary causes. Also, studies with cultured VSMC must be and showed, to our knowledge for the first time, that
interpreted with caution because phenotypic changes, calcium entry via SOC is exaggerated in preglomerular
which may arise during multiple passages, can confound VSMC of young SHR compared to normotensive WKY
results. Endogenous hormones or paracrine agents from controls. One could reason that if SR calcium stores
the endothelium can substantially alter pathways of cal- were greater in SHR, then any mechanism to empty
cium signaling and vascular contraction. these stores should resulted in greater opening of SOC
The aim of the present investigation was to compare channels. Studies performed in large systemic arteries
calcium entry and mobilization mechanisms in freshly have suggested that SR calcium stores are increased in
prepared preglomerular VSMC derived from 5- to 6-week- adult SHR (9 to 10 and 13 weeks old) [41, 42]. Thus, it
is crucial to examine the extent of calcium mobilizationold SHR and WKY. We selected the vasopressin-1 recep-
Fellner and Arendshorst: Store-operated Ca2 entry in SHR 2139
induced by IP3 or ryanodine receptor activation, or by channel independently of an action on IP3 receptors
[29–31]. Because IP3 is not involved in ryanodine activa-an SR Ca2-ATPase inhibitor in calcium-free medium.
Our studies of preglomerular VSMC in calcium-free tion of the RyR, 2-APB serves as a very useful tool for
selectively blocking the SOC channel, independent ofmedium with V1R show a 66% greater degree of puta-
tively IP3-mediated mobilization of SR Ca2 in SHR ver- IP3 receptor activity. Since pretreating preglomerular
VSMC with 2-APB appears to block SOC, then stimula-sus WKY. Given that SHR have a higher density of V1
receptors [4], this is not an unexpected finding if one tion of the VSMC with ryanodine should represent only
SR calcium mobilization. In the presence of 2-APB theassumes that signal transduction is directly proportional
to the number of receptors that are stimulated. Thus, it increase in [Ca2]i due to ryanodine stimulation of the
RyR was not different in SHR and WKY. Furthermore,is not possible to know if the enhanced SOC in SHR is
a consequence of greater emptying of SR calcium stores it was of the same magnitude as that of ryanodine-
induced calcium mobilization in calcium-free buffer [16].or of a greater density or open probability of SOC chan-
nels in genetically hypertensive rats. Therefore, we per- These data reconfirm that SR calcium mobilization en-
gendered by stimulation of the RyR is not different informed studies in which calcium depletion of the SR was
not dependent upon V1R activation of phospholipase C WKY and SHR, but that calcium entry via SOC is magni-
fied in SHR.and IP3 mechanisms.
Our prior study found that preglomerular VSMC of Cyclopiazonic acid, by inhibiting the SR Ca2-ATPase,
depletes SR calcium by preventing refilling, a mechanismWKY have RyR and that stimulation of the RyR with
ryanodine or caffeine activates SOC [16]. In the current different from IP3 or ryanodine stimulation of channel
opening and release of calcium into the cytosol. Butstudy, the ryanodine-induced mobilization response of
VSMC in calcium-free buffer was not different between independent of the manner of SR calcium depletion,
SOC is activated [16]. The current study shows that treat-WKY and SHR. In contrast, when calcium was added
to the extracellular medium, calcium entry during block- ment of preglomerular VSMC with CPA, when calcium
entry is prevented by EGTA and nifedipine containingade of L-channels was more than doubled in SHR, sug-
gesting that SHR have a greater increase in SOC activity, calcium-free buffer, increases [Ca2]i to the same extent
in SHR and WKY. However, when calcium entry inde-at least when the contribution of SOC was magnified by
prior depletion of SR calcium stores. It appears that the pendent of L-type channels is permitted by adding cal-
cium to the external medium, SOC is more than twofoldcoupling of SOC to depletion of calcium stores may
vary according to the stimulus responsible for calcium greater in SHR.
Taken together, our results with ryanodine and CPAmobilization. Our results suggest that the efficacy of such
coupling may be greater for RyR than for IP3 receptor in calcium-free medium and with 2-APB given before
or after stimulation with ryanodine are novel in demon-activation.
To further document the finding that SHR have exag- strating that VSMC derived from renal resistance vessels
of SHR have greatly increased SOC compared to WKY.gerated SOC activity, we treated preglomerular VSMC
in calcium-free buffer with the Ca2-ATPase inhibitor Only one other study has sought differences in capacita-
tive calcium entry in SHR and WKY. Cultured thoracicCPA to prevent refilling of SR calcium stores. The aver-
age responses in SHR and WKY did not differ, sug- aorta VSMC from young rats of both strains showed an
enhanced degree of mobilization in response to Ang IIgesting that the extent of depletion of SR calcium was
similar. Addition of external calcium clearly caused more as well as greater capacitative calcium entry in SHR
[43]. Their experimental protocol did not include Mn2than a twofold greater entry of calcium in SHR versus
WKY. Thus, by utilizing two separate non-IP3 dependent quenching to confirm divalent cation entry. In separate
experiments, these investigators did not find an alter-mechanisms to deplete SR calcium stores, we have dem-
onstrated that SOC activity is substantially exaggerated ation of calcium influx with nifedipine (5 mol/L), sug-
gesting that SOC was the major pathway for calciumin SHR.
Gadolinium (108 to 106 mol/L) is a selective and entry.
We have considered whether changes in plasmalem-irreversible inhibitor of SOC [25]. Our studies showing
that Gd3 (107 to 106 mol/L) inhibited the [Ca2]i re- mal Ca2-ATPase in SHR and WKY could account for
our findings. Because 2-APB at concentrations of 75sponse to ryanodine and to V1R in preglomerular VSMC
provides additional evidence that calcium entry occurred mol/L or less and gadolinium have no effect on the
plasmalemmal Ca2-ATPase to our knowledge, our datavia SOC.
To further confirm that SOC activity is exaggerated showing inhibition of SOC with these two agents would
not support a role for a strain difference in Ca2-ATPasein SHR, we employed the reagent 2-APB. This cell per-
meant compound has been used to block the IP3 receptor activity. That SHR and WKY responded identically to
CPA suggests that there is not a strain difference inin a variety of cell preparations [26–28]. More recently,
however, 2-APB has been shown to inhibit the SOC sarcolemmal Ca2-ATPase activity as well.
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An important consideration in the interpretation of rats, as well as from WKY obtained from a commercial
supplier. Our laboratory consistently finds comparablethe three separate mechanisms (IP3, RyR and CPA) for
depleting the SR of calcium is the spatial arrangement differences between SHR and these three normotensive
strains.of IP3 receptors and RyR on the SR. Are there separate
or common compartments of calcium stores served by In summary, we have demonstrated, by three distinct
mechanisms that deplete the SR of calcium, that youngthese two classes of channels? Does inhibition of SR
Ca2-ATPase affect one or both storage sites? If there SHR have exaggerated SOC in preglomerular VSMC
compared to normotensive WKY. Mobilization of SRare separate compartments, do they interconnect? Some
studies of VSMC suggest that RyR and IP3 receptors calcium following V1R-induced interaction with G pro-
teins, activation of phospholipase C and generation ofinvolve overlapping or interconnecting storage sites and
others do not [44–47]. The spatial arrangement of IP3 IP3 is greater in SHR. In contrast, ryanodine stimulation
of the RyR does not cause a discernible difference inreceptors and RyR on the SR of preglomerular arterioles
is currently not known. mobilization between the two strains; nor does CPA
block reuptake of calcium into the SR differently. In theCalcium entry via voltage-gated L-type channel has
been reported to vary from 45 to nearly 100% in preglo- presence of inhibitors of voltage-gated L-type channels,
both calcium-free medium and inhibitors of SOC, 2-APBmerular vessels in different rat strains and experimental
preparations [15, 17, 23, 40, 48–52]. Only one study, per- and Gd3, prevented calcium entry via SOC. We con-
formed in 30-week-old rats with established hyperten- firmed that vasopressin-1 receptor activation causes a
sion, examined L-channel protein density with Western greater global response in SHR and that the percent
blot analyses in renal resistance arterioles in SHR and inhibition by blockade of L-channels with nifedipine is
WKY, and found no difference between the two strains similar in SHR and WKY.
[14]. On the other hand, functional studies of renal blood
flow performed on 7-week-old SHR and WKY indicate ACKNOWLEDGMENTS
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